Bain Capital Specialty Finance, Inc.

As of August 8, 2025, Bain Capital Specialty Finance, Inc. shows a mildly bearish technical trend, with mixed indicators suggesting short-term weakness and underperformance compared to the S&P 500.

As of February 24, 2021, Bain Capital Specialty Finance, Inc. is considered undervalued with a P/E ratio of 9, a Price to Book Value of 0.89, and a high dividend yield of 11.45%, despite a year-to-date return of -15.18%, indicating potential for recovery compared to its peers.

As of February 24, 2021, Bain Capital Specialty Finance, Inc. is considered undervalued with a valuation grade of very attractive, featuring a P/E ratio of 9, a Price to Book Value of 0.89, and a high Dividend Yield of 11.45%, making it a compelling investment opportunity despite underperforming against the S&P 500.

As of June 17, 2025, Bain Capital Specialty Finance, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD, Bollinger Bands, and moving averages, despite some mixed signals from the KST and Dow Theory.

As of March 2022, the management team of Bain Capital Specialty Finance, Inc. includes Chairman Jeffrey Hawkins, CEO Michael Ewald, and six independent directors: Amy Butte, David Fubini, Thomas Hough, Jay Margolis, and Clare Richer. They oversee the company's strategic direction and operations.

Bain Capital Specialty Finance, Inc. is a managed specialty finance company that lends to middle market companies in the finance industry, with a recent market cap of approximately $965 million. Key financial metrics include a P/E ratio of 9.00 and a dividend yield of 15.05%.

As of Jun 18, Bain Capital Specialty Finance, Inc. has a market capitalization of 965.24 million, with net sales of 246.58 million and a net profit of 112.88 million over the latest four quarters. The balance sheet shows shareholder's funds of 1,139.67 million and total assets of 2,632.16 million.